Promoting Biosecurity in Cell and Gene Therapy Production
Your facility can be significantly impacted by microbial contamination, presenting notable financial, operational, and clinical risks. CURIS recognizes the critical nature of a clean cell line in gene therapy and the importance of maintaining sterile conditions during cell handling.
Upholding Sterile Conditions in Therapy Advancement
CURIS' flexible decontamination solutions help to create a secure, contaminant-free environment, allowing for efficient disinfection in cell and gene therapy processes. Our commitment is to support the safe development of pioneering therapies, mitigating risks, and ensuring biosecurity in gene therapy operations.
Decontamination Solutions for:
Aseptic Manipulation | Streamline Improvements | Equipment Decontamination
In gene, cell, and CAR-T therapies, aseptic manipulation is essential. CURIS' advanced decontamination systems enhance these sterile conditions, improving treatment precision and efficiency while minimizing contamination risks. With CURIS, you can maintain GMP compliance in cell and gene therapy and expand patient treatment capabilities.
CURIS decontamination systems offer a streamlined approach to gene and cell therapy processes, reducing space, energy, and risk exposure. Our contamination control technology enables quick, safe cell handling in controlled aseptic conditions, with decontaminated tools aiding precision-driven gene therapy.
CURIS provides custom decontamination solutions for diverse equipment, suitable for maintaining cleanroom sterility in cell therapy. Our hydrogen peroxide systems are adaptable for diverse applications and ideal for equipment such as isolators, biological safety cabinets, incubators, and lyophilizers.